chloroquine and 3-methyladenosine

chloroquine has been researched along with 3-methyladenosine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boldorini, R; Canonico, PL; Di Lisa, F; Drago, V; Galli, U; Genazzani, AA; Kaludercic, N; Maldi, E; Travelli, C; Tron, GC	1
Cheng, Y; Liu, D; Patel, R; Qin, ZH; Ren, X; Shih, IM; Wu, H; Yang, JM; Yap, KL; Zhang, L; Zhang, Y	1

Other Studies

2 other study(ies) available for chloroquine and 3-methyladenosine

Article	Year
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 338, Issue:3 Topics: Acrylamides; Adenosine; Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chloroquine; Cisplatin; Comet Assay; DNA Damage; Down-Regulation; Drug Synergism; Etoposide; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neuroblastoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Ubiquitin-Activating Enzymes	2011
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene, 2012, Feb-23, Volume: 31, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein	2012

Article

Year

Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells.

The Journal of pharmacology and experimental therapeutics, 2011, Volume: 338, Issue:3

Topics: Acrylamides; Adenosine; Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chloroquine; Cisplatin; Comet Assay; DNA Damage; Down-Regulation; Drug Synergism; Etoposide; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neuroblastoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Ubiquitin-Activating Enzymes

2011

NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.

Oncogene, 2012, Feb-23, Volume: 31, Issue:8

Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein

2012